The long term goal is to elucidate the processes by which mitogenic signals are relayed intracellularly, and to apply this information to understanding how normal growth control is deregulated enabling the progression of lung cancer. Among the differences between normal and tumor lung cells is that the tumor cells secrete increased concentrations of growth factors, which in some instances drive the increased growth rate of the tumors. Thus one of the mechanisms by which normal lung tissue becomes tumorigenic involves increased concentrations of growth factors. However, increased concentrations of growth factors alone are probably not enough to cause lung tumors, since chronic stimulation of tissue culture cells with high levels of growth factors does not usually lead to transformation. More often, cells become transformed when they overexpress and/or harbor mutations within their growth factor receptors. The short-term goal, to be addressed in this research proposal, is to test whether progression of normal lung cells to the malignant state involves both the increased production of growth factors and the mutation and/or overexpression of growth factor receptors. The first specific aim will define the incidence of overexpression and mutation of known growth factor receptors, while the second specific aim will focus on identifying novel lung-specific receptor tyrosine kinases. In the third specific aim, the biological significance of the first two specific aims will be tested. The mutant and novel receptors will be expressed in normal lung tissue to test whether they act as oncogenes. The effect of growth factor stimulation on the ability to transform will also be determined. Finally, we will test the contribution of the identified growth factor receptors to the progression of lung cells from the premalignant to the tumorigenic state. The direct benefit of understanding the role of growth factors and their receptors in the progression of lung tumors will significantly contribute to both prognosis of the stage of a lung tumor, as well as the treatment and management of lung tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA058187-03
Application #
3751690
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kimball, Abigail K; Oko, Lauren M; Bullock, Bonnie L et al. (2018) A Beginner's Guide to Analyzing and Visualizing Mass Cytometry Data. J Immunol 200:3-22
Tippimanchai, Darinee D; Nolan, Kyle; Poczobutt, Joanna et al. (2018) Adenoviral vectors transduce alveolar macrophages in lung cancer models. Oncoimmunology 7:e1438105
DeHart, David N; Lemasters, John J; Maldonado, Eduardo N (2018) Erastin-Like Anti-Warburg Agents Prevent Mitochondrial Depolarization Induced by Free Tubulin and Decrease Lactate Formation in Cancer Cells. SLAS Discov 23:23-33
Ren, Shengxiang; Zhang, Shucai; Jiang, Tao et al. (2018) Early detection of lung cancer by using an autoantibody panel in Chinese population. Oncoimmunology 7:e1384108
Davies, Kurtis D; Le, Anh T; Sheren, Jamie et al. (2018) Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples. J Thorac Oncol 13:1474-1482
Iams, Wade T; Yu, Hui; Shyr, Yu et al. (2018) First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance. Clin Lung Cancer 19:531-543
McDaniel, Nellie K; Cummings, Christopher T; Iida, Mari et al. (2018) MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents. Mol Cancer Ther 17:2297-2308
Ghosh, Moumita; Miller, York E; Vandivier, R William et al. (2018) Reply to Sohal: Airway Basal Cell Reprogramming and Epithelial-Mesenchymal Transition: A Potential Key to Understanding Early Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197:1645-1646
Ghosh, Moumita; Miller, York E; Nakachi, Ichiro et al. (2018) Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197:885-896
Farago, Anna F; Taylor, Martin S; Doebele, Robert C et al. (2018) Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion. JCO Precis Oncol 2018:

Showing the most recent 10 out of 435 publications